Cathepsin D and Ovarian Cancer Prognosis
Author Information
Author(s): G Ferrandina, G Scambia, A Fagotti, G D'Agostino, P Benedetti Panicci, A Carbone, S Mancuso
Primary Institution: Catholic University, Rome, Italy
Hypothesis
What is the clinical significance of Cathepsin D levels in ovarian cancer?
Conclusion
Cathepsin D measurement in tumor extracts has limited usefulness in improving the prognostic characterization of ovarian cancer patients.
Supporting Evidence
- No correlation was found between Cathepsin D levels and clinicopathological parameters.
- The percentage of Cathepsin D positivity was significantly higher in estrogen receptor-positive cases.
- The 5-year overall survival rate was similar for Cathepsin D-positive and Cathepsin D-negative patients.
Takeaway
This study looked at a protein called Cathepsin D in ovarian cancer to see if it could help predict how patients would do, but it turns out it doesn't really help.
Methodology
The study analyzed Cathepsin D levels in tumor samples from 162 untreated ovarian cancer patients using immunoradiometric and immunohistochemical assays.
Limitations
The study may have included tumor samples with invading stromal and inflammatory cell contaminants, which could affect the results.
Participant Demographics
162 previously untreated patients with histologically confirmed ovarian carcinoma.
Statistical Information
P-Value
p=0.69
Statistical Significance
p=0.01
Want to read the original?
Access the complete publication on the publisher's website